Indaptus Therapeutics, Inc.
INDP
$2.57
$0.4923.56%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -13.35% | -68.58% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -16.24% | -73.52% | |||
| Operating Income | 16.24% | 73.52% | |||
| Income Before Tax | 29.37% | 68.68% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 29.37% | 68.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 29.37% | 68.68% | |||
| EBIT | 16.24% | 73.52% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 93.32% | 94.86% | |||
| Normalized Basic EPS | 93.31% | 94.86% | |||
| EPS Diluted | 93.32% | 94.86% | |||
| Normalized Diluted EPS | 93.31% | 94.86% | |||
| Average Basic Shares Outstanding | 959.91% | 509.72% | |||
| Average Diluted Shares Outstanding | 959.91% | 509.72% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||